1. Home
  2. Children's Antibiotics
Global Antibiotic Research and Development Partnership

Children's Antibiotics

Last updated: 07/08/2020
IATI Identifier: CH-FDJP-CHE331930936-NNS-19
Project disclaimer
Disclaimer: The data for this page has been produced from IATI data published by Global Antibiotic Research and Development Partnership. Please contact them (Show Email Address) if you have any questions about their data.


Globally, infectious diseases such as pneumonia and sepsis are the leading cause of death and disability in children under five and are responsible for more than 3 million deaths a year. The situation is worsened by drug-resistant infections, as the limited number of treatments for children and babies are becoming less effective. More than 214,000 babies die each year from drug-resistant infections. Most of these deaths occur in low- and middle-countries.


The country, countries or regions that benefit from this Programme.
Global project
Disclaimer: Country borders do not necessarily reflect the UK Government's official position.

Status Implementation

The current stage of the Programme, consistent with the International Aid Transparency Initiative's (IATI) classifications.

Programme Spend

Programme budget and spend to date, as per the amounts loaded in financial system(s), and for which procurement has been finalised.

Participating Organisation(s)

Help with participating organisations
These organisations have received funding disbursements from this IATI activity.


Sector groups as a percentage of total Programme budget according to the OECD Development Assistance Committee (DAC) classifications.


A comparison across financial years of forecast budget and spend to date on the Programme.

Download IATI Data for CH-FDJP-CHE331930936-NNS-19

Programme data last updated on 07/08/2020